Top Markets
#1 Nesa Nesa +803.49%
#2 Cortex Cortex +68.67%
#3 Kinesis Silver Kinesis Silver +55.82%
#4 Merlin's Seal BTC Merlin's Seal BTC +45.67%
#5 QuantixAI QuantixAI +24.00%
#6 EXOD EXOD +22.78%
#7 Cash Cat Cash Cat +22.43%
#8 Alchemist AI Alchemist AI +17.55%
#9 Pons Pons +16.98%
#10 Instadapp Instadapp +16.15%
Coin of the day
Nesa Nesa
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Jyong Biotech Ltd. Ordinary Shares Jyong Biotech Ltd. Ordinary Shares

Jyong Biotech Ltd. Ordinary Shares

MENS
Kedudukan dalam Saham #19258
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the... Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidates, which notably features MCS-2, currently undergoing Phase III trials for benign prostatic hyperplasia (BPH); PCP, which is in Phase II development for prostate cancer; and IC, presently in pre-clinical stages.
Harga Saham
$2.22
Disegerakkan terakhir: 2026-08-25
Modal Pasaran
$168.64M
Perubahan (1 hari)
-0.09%
Perubahan (1 tahun)
-95.58%
Negara
TW
Perdagangan Jyong Biotech Ltd. Ordinary Shares (MENS)

Kategori

Healthcare
Pendapatan untuk Jyong Biotech Ltd. Ordinary Shares (MENS)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Jyong Biotech Ltd. Ordinary Shares, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Jyong Biotech Ltd. Ordinary Shares dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH